301 related articles for article (PubMed ID: 21214365)
1. DBCAT: database of CpG islands and analytical tools for identifying comprehensive methylation profiles in cancer cells.
Kuo HC; Lin PY; Chung TC; Chao CM; Lai LC; Tsai MH; Chuang EY
J Comput Biol; 2011 Aug; 18(8):1013-7. PubMed ID: 21214365
[TBL] [Abstract][Full Text] [Related]
2. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells.
Gebhard C; Benner C; Ehrich M; Schwarzfischer L; Schilling E; Klug M; Dietmaier W; Thiede C; Holler E; Andreesen R; Rehli M
Cancer Res; 2010 Feb; 70(4):1398-407. PubMed ID: 20145141
[TBL] [Abstract][Full Text] [Related]
3. Analyzing epigenome data in context of genome evolution and human diseases.
Feuerbach L; Halachev K; Assenov Y; Müller F; Bock C; Lengauer T
Methods Mol Biol; 2012; 856():431-67. PubMed ID: 22399470
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel approach, the epigenome-based outlier approach, to identify tumor-suppressor genes silenced by aberrant DNA methylation.
Kikuyama M; Takeshima H; Kinoshita T; Okochi-Takada E; Wakabayashi M; Akashi-Tanaka S; Ogawa T; Seto Y; Ushijima T
Cancer Lett; 2012 Sep; 322(2):204-12. PubMed ID: 22433712
[TBL] [Abstract][Full Text] [Related]
5. Analysis of promoter CpG island hypermethylation in cancer: location, location, location!
van Vlodrop IJ; Niessen HE; Derks S; Baldewijns MM; van Criekinge W; Herman JG; van Engeland M
Clin Cancer Res; 2011 Jul; 17(13):4225-31. PubMed ID: 21558408
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status.
Arai E; Kanai Y
Epigenomics; 2010 Jun; 2(3):467-81. PubMed ID: 22121905
[TBL] [Abstract][Full Text] [Related]
7. Effect of CpG methylation on DNA binding protein: molecular dynamics simulations of the homeodomain PITX2 bound to the methylated DNA.
Yang SY; Yang XL; Yao LF; Wang HB; Sun CK
J Mol Graph Model; 2011 Jun; 29(7):920-7. PubMed ID: 21498098
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide profiling of DNA methylation in human cancer cells.
Ogoshi K; Hashimoto S; Nakatani Y; Qu W; Oshima K; Tokunaga K; Sugano S; Hattori M; Morishita S; Matsushima K
Genomics; 2011 Oct; 98(4):280-7. PubMed ID: 21821115
[TBL] [Abstract][Full Text] [Related]
9. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
10. Predicting methylation status of CpG islands in the human brain.
Fang F; Fan S; Zhang X; Zhang MQ
Bioinformatics; 2006 Sep; 22(18):2204-9. PubMed ID: 16837523
[TBL] [Abstract][Full Text] [Related]
11. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells.
Shen Y; Chow J; Wang Z; Fan G
Hum Mol Genet; 2006 Sep; 15(17):2623-35. PubMed ID: 16870691
[TBL] [Abstract][Full Text] [Related]
12. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
[TBL] [Abstract][Full Text] [Related]
13. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation.
Tang H; Goldberg E
J Androl; 2009; 30(2):157-67. PubMed ID: 18930904
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of multidrug resistance 1 gene expression: profiling CpG methylation status using bisulphite sequencing.
Baker EK; El-Osta A
Methods Mol Biol; 2010; 596():183-98. PubMed ID: 19949925
[TBL] [Abstract][Full Text] [Related]
15. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors.
Stirzaker C; Millar DS; Paul CL; Warnecke PM; Harrison J; Vincent PC; Frommer M; Clark SJ
Cancer Res; 1997 Jun; 57(11):2229-37. PubMed ID: 9187126
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation differences associated with tumor tissues identified by genome scanning analysis.
Liang G; Salem CE; Yu MC; Nguyen HD; Gonzales FA; Nguyen TT; Nichols PW; Jones PA
Genomics; 1998 Nov; 53(3):260-8. PubMed ID: 9799591
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
19. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
20. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines.
Guilleret I; Benhattar J
Biochem Biophys Res Commun; 2004 Dec; 325(3):1037-43. PubMed ID: 15541393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
